首页> 外国专利> Method of the cell marking by means of complex nitride - bis (dithiocarbamate) - 99m tc and kit for óoeuvre of this process.

Method of the cell marking by means of complex nitride - bis (dithiocarbamate) - 99m tc and kit for óoeuvre of this process.

机译:通过复杂的氮化物-双(二硫代氨基甲酸酯)-99m tc进行细胞标记的方法以及用于该过程的试剂盒。

摘要

Process for radiolabelling cells comprises adding a compsn. comprising a Tc-99m nitride complex of formula (TCEN)L1L2 (I) to a suspension of the cells; L1, L2 = dithiocarbamate ligands of formula R1NEt-C(S)-S, R1 = Et or OEt, provided that L1 and/or L2 has R1 = OEt. Also claimed are: (1) a radiopharmaceutical compsn. comprising a suspension of cells labelled with (I) where L1 and L2 = (II); R1 = OEt). (2) a radiopharmaceutical compsn. comprising a suspension of granulocytes labelled with (I) as defined above without the proviso. USE/ADVANTAGE - The process is useful for labelling blood cells, e.g. leucocytes, esp. granulocytes, esp. for localising sites of inflammation or infection. Leucocytes are labelled with high efficiency (e.g. 85-94% of radioactivity incorporated into cells) and with high selectivity over other cells esp. erythrocytes and platelets.
机译:放射性标记细胞的过程包括添加化合物。包含式(TCEN)L1L2(I)的Tc-99m氮化物配合物至细胞的悬浮液; L1,L2 =式R1NEt-C(S)-S的二硫代氨基甲酸酯配体,R1 = Et或OEt,条件是L1和/或L2具有R1 = OEt。还要求保护的是:(1)放射性药物组合物。包括用(I)标记的细胞的悬浮液,其中L1和L2 =(II); R1 = OEt)。 (2)放射性药物组合物。包含无条件的如上定义的用(I)标记的粒细胞悬浮液。使用/优势-该过程可用于标记血细胞,例如白细胞,特别是粒细胞,特别是用于定位炎症或感染部位。白细胞被高效标记(例如掺入细胞的放射性的85-94%),并且具有比其他细胞更高的选择性,尤其是。红细胞和血小板。

著录项

  • 公开/公告号FR2698272B1

    专利类型

  • 公开/公告日1994-12-30

    原文格式PDF

  • 申请/专利权人 CIS BIO INT;

    申请/专利号FR19920013963

  • 发明设计人 ROBERTO PASQUALINI;ANNICK MOISAN;

    申请日1992-11-20

  • 分类号A61K49/02;G21H5/02;

  • 国家 FR

  • 入库时间 2022-08-22 04:07:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号